I worked as an engineer at Abbott Vascular and a smaller startup, but I felt an urge to start my own company at 24, driven by my past health experiences.

I aimed to build my company to deliver a product that could quickly provide answers for women with complex cysts, helping them avoid unnecessary interventions if they weren't cancerous.

I co-founded Bellabeat, a company focused on designing beautiful and user-friendly technology for tracking women's health.

An unexpected health scare motivated me to start my own company, which I eventually sold to Boston Scientific for $275 million.

As a female founder, I realized that fundraising is particularly challenging, and I wanted to help level the playing field for future female entrepreneurs.

To validate my concept for a new device in women's health, I reached out to gynecologists, even pretending to have a stomach ache to get an appointment with one.

A group of female entrepreneurs at the hospital in India pooled their resources to save for healthcare, demonstrating the power of community and direct relationships in addressing needs.

After a health scare in my family, I reassessed my priorities and realized the importance of self-care for long-term sustainability.

After selling my company, I was invited to be the first healthcare and biotech partner at Y Combinator, where I could share my story and help other founders.